Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 9 Human Immunoglobulins.

Literature DB >> 21245975

9 Human Immunoglobulins.

Abstract

Entities: Species

Year: 2009 PMID： 21245975 PMCID： PMC2997299

Source DB: PubMed Journal: Transfus Med Hemother ISSN： 1660-3796 Impact factor: 3.747

× No keyword cloud information.

120 in total

Review 1. The alloimmune thrombocytopenias: neonatal alloimmune thrombocytopenic purpura and post-transfusion purpura.

Authors: T J Kunicki; D S Beardsley
Journal: Prog Hemost Thromb Date: 1989

2. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors: Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal: Science Date: 2006-08-04 Impact factor: 47.728

3. Active vaccination in patients with common variable immunodeficiency (CVID).

Authors: S Goldacker; R Draeger; K Warnatz; D Huzly; U Salzer; J Thiel; H Eibel; M Schlesier; H H Peter
Journal: Clin Immunol Date: 2007-06-29 Impact factor: 3.969

4. Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients.

Authors: J T Wittes; A Kelly; K M Plante
Journal: Transplant Proc Date: 1996-12 Impact factor: 1.066

5. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

Authors: Y Sultan; M D Kazatchkine; P Maisonneuve; U E Nydegger
Journal: Lancet Date: 1984-10-06 Impact factor: 79.321

6. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.

Authors: V Blanchette; P Imbach; M Andrew; M Adams; J McMillan; E Wang; R Milner; K Ali; D Barnard; M Bernstein
Journal: Lancet Date: 1994-09-10 Impact factor: 79.321

7. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.

Authors: J R Mendell; R J Barohn; M L Freimer; J T Kissel; W King; H N Nagaraja; R Rice; W W Campbell; P D Donofrio; C E Jackson; R A Lewis; M Shy; D M Simpson; G J Parry; M H Rivner; C A Thornton; M B Bromberg; R Tandan; Y Harati; M J Giuliani
Journal: Neurology Date: 2001-02-27 Impact factor: 9.910

Review 8. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.

Authors: M C Dalakas
Journal: Muscle Nerve Date: 1999-11 Impact factor: 3.217

9. Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment.

Authors: N Ahrens; C Höflich; S Bombard; H Lochs; H Kiesewetter; A Salama
Journal: Clin Exp Immunol Date: 2008-03 Impact factor: 4.330

10. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.

Authors: A A Fanaroff; S B Korones; L L Wright; E C Wright; R L Poland; C B Bauer; J E Tyson; J B Philips; W Edwards; J F Lucey
Journal: N Engl J Med Date: 1994-04-21 Impact factor: 91.245

1 in total

Review 1. Immunoglobulin for multifocal motor neuropathy.

Authors: Stephen Keddie; Filip Eftimov; Leonard H van den Berg; Ruth Brassington; Rob J de Haan; Ivo N van Schaik
Journal: Cochrane Database Syst Rev Date: 2022-01-11

1 in total